Alfuzosin
Alfuzosin hydrochloride extended-release tablets, USP are indicated for the treatment of signs and symptoms of benign prostatic hyperplasia.
United States
$9
per month
India
$1
per month
You save
−85%save $8/mo · 85% cheaper
1.1M US scripts/yr$8.4M potential annual savings$9.8M US spend/yr
Drag to rotate · 3D structureC19H27N5O4
SMILES: CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC
Compare the price
US price$9per month
India price$1per month
You save$885% less
Based on 30 units per month. US $0.30 vs India $0.04 per unit.
Total over 1 periodSave $8$9 → $1
The bigger picture
Alfuzosin is filled about 1.1M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$9.8M
If sourced from India
$1.4M
Potential annual savings
$8.4M
−85%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.